REFERENCES
1. Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res 2016;118:535-46.
2. Barquera S, Pedroza-Tobías A, Medina C, Hernández-Barrera L, Bibbins-Domingo K, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res 2015;46:328-38.
3. Moran AE, Tzong KY, Forouzanfar MH, Rothy GA, Mensah GA, et al. Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. Glob Heart 2014;9:91-9.
4. Cairns BJ, Balkwill A, Canoy D, Green J, Reeves GK, et al; Million Women Study Collaborators. Variations in vascular mortality trends, 2001-2010, among 1.3 million women with different lifestyle risk factors for the disease. Eur J Prev Cardiol 2015;22:1626-34.
5. Li K, Hüsing A, Kaaks R. Lifestyle risk factors and residual life expectancy at age 40: a German cohort study. BMC Med 2014;12:59.
6. Gimbrone MA Jr, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 2016;118:620-36.
7. Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, et al. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol 2014;34:790-800.
8. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006;37:1923-32.
9. Libby P, Bornfeldt KE, Tall AR. Atherosclerosis: successes, surprises, and future challenges. Circ Res 2016;118:531-4.
10. Rader DJ. Human genetics of atherothrombotic disease and its risk factors. Arterioscler Thromb Vasc Biol 2015;35:741-7.
11. Dron JS, Ho R, Hegele RA. Recent advances in the genetics of atherothrombotic disease and its determinants. Arterioscler Thromb Vasc Biol 2017;37:e158-66.
12. Boulanger CM, Loyer X, Rautou PE, Amabile N. Extracellular vesicles in coronary artery disease. Nat Rev Cardiol 2017;14:259-72.
13. Nguyen MA, Karunakaran D, Geoffrion M, Cheng HS, Tandoc K, et al. Extracellular vesicles secreted by atherogenic macrophages transfer microRNA to inhibit cell migration. Arterioscler Thromb Vasc Biol 2018;38:49-63.
14. Deng W, Tang T, Hou Y, Zeng Q, Wang Y, et al. Extracellular vesicles in atherosclerosis. Clin Chim Acta 2019;495:109-17.
15. Hafiane A, Daskalopoulou SS. Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease. Metabolism 2018;85:213-22.
16. Boilard E. Extracellular vesicles and their content in bioactive lipid mediators: more than a sack of microRNA. J Lipid Res 2018;59:2037-46.
17. Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018;7:1535750.
18. Clayton A, Boilard E, Buzas EI, Cheng L, Falcón-Perez JM, et al. Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. J Extracell Vesicles 2019;8:1647027.
19. Hill AF, Pegtel DM, Lambertz U, Leonardi T, O’Driscoll L, et al. ISEV position paper: extracellular vesicle RNA analysis and bioinformatics. J Extracell Vesicles 2014;2:22859.
20. Raimondo F, Morosi L, Chinello C, Magni F, Pitto M. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 2011;11:709-20.
21. Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, et al. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci 2013;14:5338-66.
22. Tual-Chalot S, Leonetti D, Andriantsitohaina R, Martinez MC. Microvesicles: intercellular vectors of biological messages. Mol Interv 2011;11:88-94.
23. Soo CY, Song YQ, Zheng Y, Campbell EC, Riches AC, et al. Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology 2012;136:192-7.
24. Huang XY, Yuan TZ, Tschannen M, Sun ZF, Jacob H, et al. Characterization of human plasma-derived exosomal rnas by deep sequencing. BMC Genomics 2013;14:14.
25. de Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, et al. Cellular stress conditions are reflected in the protein and rna content of endothelial cell-derived exosomes. J Extracell Vesicles 2012;1.
26. Waldenstrom A, Genneback N, Hellman U, Ronquist G. Cardiomyocyte microvesicles contain dna/rna and convey biological messages to target cells. PLoS One 2012;7:7.
27. Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, et al. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 2011;1:98-110.
28. Caruso S, Poon IKH. Apoptotic cell-derived extracellular vesicles: more than just debris. Front Immunol 2018;9:1486.
29. Boon RA, Vickers KC. Intercellular transport of micrornas. Arterioscler Thromb Vasc Biol 2013;33:186-92.
30. Gump JM, Thorburn A. Autophagy and apoptosis: what is the connection? Trends Cell Biol 2011;21:387-92.
31. Jiang L, Paone S, Caruso S, Atkin-Smith GK, Phan TK, et al. Determining the contents and cell origins of apoptotic bodies by flow cytometry. Sci Rep 2017;7:14444.
32. Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol 2013;113:1-11.
33. Orlando KA, Stone NL, Pittman RN. Rho kinase regulates fragmentation and phagocytosis of apoptotic cells. Exp Cell Res 2006;312:5-15.
34. Tasdemir E, Galluzzi L, Maiuri MC, Criollo A, Vitale I, et al. Methods for assessing autophagy and autophagic cell death. Methods Mol Biol 2008;445:29-76.
35. Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009;6:267-83.
36. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010;107:1047-57.
37. El Andaloussi S, Maeger I, Breakefield XO, Wood MJA. Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013;12:348-58.
38. Yu X, Deng LY, Wang D, Li N, Chen X, et al. Mechanism of TNF-alpha autocrine effects in hypoxic cardiomyocytes: Initiated by hypoxia inducible factor 1 alpha, presented by exosomes. J Mol Cell Cardiol 2012;53:848-57.
39. Tian J, Guo X, Liu XM, Liu L, Weng QF, et al. Extracellular hsp60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes. Cardiovasc Res 2013;98:391-401.
40. Hoyer FF, Nickenig G, Werner N. Microparticles - messengers of biological information. J Cell Mol Med 2010;14:2250-6.
41. Todorova D, Simoncini S, Lacroix R, Sabatier F, Dignat-George F. Extracellular vesicles in angiogenesis. Circ Res 2017;120:1658-73.
42. Bagi Z, Couch Y, Broskova Z, Perez-Balderas F, Yeo T, et al. Extracellular vesicle integrins act as a nexus for platelet adhesion in cerebral microvessels. Sci Rep 2019;9:15847.
43. Figliolini F, Ranghino A, Grange C, Cedrino M, Tapparo M, et al. Extracellular vesicles from adipose stem cells prevent muscle damage and inflammation in a mouse model of hind limb ischemia: role of neuregulin-1. Arterioscler Thromb Vasc Biol 2020;40:239-54.
44. Chatterjee V, Yang X, Ma Y, Cha B, Meegan JE, et al. Endothelial microvesicles carrying Src-rich cargo impair adherens junction integrity and cytoskeleton homeostasis. Cardiovasc Res 2019:cvz238.
45. Berezin A. Neutrophil extracellular traps: The core player in vascular complications of diabetes mellitus. Diabetes Metab Syndr 2019;13:3017-23.
46. Dalli J, Montero-Melendez T, Norling LV, Yin X, Hinds C, et al. Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties. Mol Cell Proteomics 2013;12:2205-19.
47. Banfi C, Brioschi M, Wait R, Begum S, Gianazza E, et al. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 2005;5:4443-55.
48. Camus SM, De Moraes JA, Bonnin P, Abbyad P, Le Jeune S, et al. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vaso occlusions in sickle cell disease. Blood 2015;125:3805-14.
49. Chang YJ, Li YS, Wu CC, Wang KC, Huang TC, et al. Extracellular microRNA-92a mediates endothelial cell-macrophage communication. Arterioscler Thromb Vasc Biol 2019;39:2492-504.
50. Loyer X, Potteaux S, Vion AC, Guérin CL, Boulkroun S, et al. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res 2014;114:434-43.
51. Liu Y, Li Q, Hosen MR, Zietzer A, Flender A, et al. Atherosclerotic conditions promote the packaging of functional microRNA-92a-3p into endothelial microvesicles. Circ Res 2019;124:575-87.
52. Fang Y, Davies PF. Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol 2012;32:979-87.
53. He S, Wu C, Xiao J, Li D, Sun Z, et al. Endothelial extracellular vesicles modulate the macrophage phenotype: Potential implications in atherosclerosis. Scand J Immunol 2018;87:e12648.
54. Wu W, Xiao H, Laguna-Fernandez A, Villarreal G Jr, Wang KC, et al. Flow-dependent regulation of kruppel-like factor 2 is mediated by microRNA-92a. Circulation 2011;124:633-41.
55. Gou L, Zhao L, Song W, Wang L, Liu J, et al. Inhibition of miR-92a Suppresses oxidative stress and improves endothelial function by upregulating heme oxygenase-1 in db/db Mice. Antioxid Redox Signal 2018;28:358-70.
56. Yang J, Dang G, Lü S, Liu H, Ma X, et al. T-cell-derived extracellular vesicles regulate B-cell IgG production via pyruvate kinase muscle isozyme 2. FASEB J 2019;33:12780-99.
57. Žėkas V, Matuzevičienė R, Karčiauskaitė D, Mažeikienė A, Burokienė N, et al. Chronic and oxidative stress association with total count of endothelial microvesicles in healthy young male plasma. Adv Clin Exp Med 2019;28:683-92.
58. Berezin AE, Kremzer AA, Samura TA, Berezina TA. Altered signature of apoptotic endothelial cell-derived microvesicles predicts chronic heart failure phenotypes. Biomark Med 2019;13:737-50.
59. Wang Z, Zhang J, Zhang S, Yan S, Wang Z, et al. MiR-30e and miR-92a are related to atherosclerosis by targeting ABCA1. Mol Med Rep 2019;19:3298-304.
60. Iaconetti C, Polimeni A, Sorrentino S, Sabatino J, Pironti G, et al. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury. Basic Res Cardiol 2012;107:296.
61. Kang S, Yang JW, Jeong JY, Park J, An HJ, et al. Size distribution of serum extracellular vesicles in mice with atherosclerosis. Pathol Res Pract 2019;215:152574.
62. Yang W, Zou B, Hou Y, Yan W, Chen T, et al. Extracellular vesicles in vascular calcification. Clin Chim Acta 2019;499:118-22.
63. Chimen M, Evryviadou A, Box CL, Harrison MJ, Hazeldine J, et al. Appropriation of GPIbα from platelet-derived extracellular vesicles supports monocyte recruitment in systemic inflammation. Haematologica 2019:haematol.2018.215145.
64. Wang Y, Xie Y, Zhang A, Wang M, Fang Z, et al. Exosomes: an emerging factor in atherosclerosis. Biomed Pharmacother 2019;115:108951.
65. Wadey RM, Connolly KD, Mathew D, Walters G, Rees DA, et al. Inflammatory adipocyte-derived extracellular vesicles promote leukocyte attachment to vascular endothelial cells. Atherosclerosis 2019;283:19-27.
66. Blaser MC, Aikawa E. Differential miRNA loading underpins dual harmful and protective roles for extracellular vesicles in atherogenesis. Circ Res 2019;124:467-9.
67. Wang J, Zhang C, Li C, Zhao D, Li S, et al. MicroRNA-92a promotes vascular smooth muscle cell proliferation and migration through the ROCK/MLCK signalling pathway. J Cell Mol Med 2019;23:3696-710.
68. Zhou J, Li YS, Nguyen P, Wang KC, Weiss A, et al. Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress. Circ Res 2013;113:40-51.
69. Liu H, Li G, Zhao W, Hu Y. Inhibition of miR-92a may protect endothelial cells after acute myocardial infarction in rats: role of KLF2/4. Med Sci Monit 2016;22:2451-62.
70. Zhang YY, Shi YN, Zhu N, Wang W, Deng CF, et al. Autophagy: a killer or guardian of vascular smooth muscle cells. J Drug Target 2020:1-7.
71. Rogg EM, Abplanalp WT, Bischof C, John D, Schulz MH, et al. Analysis of cell type-specific effects of microRNA-92a provides novel insights into target regulation and mechanism of action. Circulation 2018;138:2545-58.
72. Daniel JM, Penzkofer D, Teske R, Dutzmann J, Koch A, et al. Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury. Cardiovasc Res 2014;103:564-72.
73. Yamada NO, Heishima K, Akao Y, Senda T. Extracellular vesicles containing microRNA-92a-3p facilitate partial endothelial-mesenchymal transition and angiogenesis in endothelial cells. Int J Mol Sci 2019;20:E4406.
74. Barbati C, Vomero M, Colasanti T, Ceccarelli F, Marcosano M. Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis. Immunol Res 2018;66:655-62.
75. Kapustin AN, Chatrou ML, Drozdov I, Zheng Y, Davidson SM, et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res 2015;116:1312-23.
76. Goettsch C, Hutcheson JD, Aikawa M, Iwata H, Pham T, et al. Sortilin mediates vascular calcification via its recruitment into extracellular vesicles. J Clin Invest 2016;126:1323-36.
77. Chiva-Blanch G, Padró T, Alonso R, Crespo J, Perez de Isla L, et al. Liquid biopsy of extracellular microvesicles maps coronary calcification and atherosclerotic plaque in asymptomatic patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2019;39:945-55.
78. Creager MD, Hohl T, Hutcheson JD, Moss AJ, Schlotter F, et al. 18F-fluoride signal amplification identifies microcalcifications associated with atherosclerotic plaque instability in positron emission tomography/computed tomography images. Circ Cardiovasc Imaging 2019;12:e007835.
79. Adamson PD, Vesey AT, Joshi NV, Newby DE, Dweck MR. Salt in the wound: (18)F-fluoride positron emission tomography for identification of vulnerable coronary plaques. Cardiovasc Diagn Ther 2015;5:150-5.
80. Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol 2012;59:1539-48.
81. New SE, Goettsch C, Aikawa M, Marchini JF, Shibasaki M, et al. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res 2013;113:72-7.
82. Sodek J, Zhu B, Huynh MH, Brown TJ, Ringuette M. Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. Connect Tissue Res 2002;43:308-19.
83. Martins M, Ribeiro D, Martins A, Reis RL, Neves NM. Extracellular vesicles derived from osteogenically induced human bone marrow mesenchymal stem cells can modulate lineage commitment. Stem Cell Reports 2016;6:284-91.
84. Krohn JB, Hutcheson JD, Martínez-Martínez E, Irvin WS, Bouten CV, et al. Discoidin domain receptor-1 regulates calcific extracellular vesicle release in vascular smooth muscle cell fibrocalcific response via transforming growth factor-β signaling. Arterioscler Thromb Vasc Biol 2016;36:525-33.
85. Alique M, Ramírez-Carracedo R, Bodega G, Carracedo J, Ramírez R. Senescent Microvesicles: a novel advance in molecular mechanisms of atherosclerotic calcification. Int J Mol Sci 2018;19:E2003.
86. Blaser MC, Aikawa E. Roles and regulation of extracellular vesicles in cardiovascular mineral metabolism. Front Cardiovasc Med 2018;5:187.
87. Paone S, Baxter AA, Hulett MD, Poon IKH. Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosis. Cell Mol Life Sci 2019;76:1093-106.
88. Wei Y, Nazari-Jahantigh M, Neth P, Weber C, Schober A. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? Arterioscler Thromb Vasc Biol 2013;33:449-54.
89. Zhao Y, Li Y, Luo P, Gao Y, Yang J, et al. XBP1 splicing triggers miR-150 transfer from smooth muscle cells to endothelial cells via extracellular vesicles. Sci Rep 2016;6:28627.
90. Yin M, Loyer X, Boulanger CM. Extracellular vesicles as new pharmacological targets to treat atherosclerosis. Eur J Pharmacol 2015;763:90-103.
91. Togliatto G, Dentelli P, Rosso A, Lombardo G, Gili M, et al. PDGF-BB carried by endothelial cell-derived extracellular vesicles reduces vascular smooth muscle cell apoptosis in diabetes. Diabetes 2018;67:704-16.
92. Sanden M, Botha J, Nielsen MRS, Nielsen MH, Schmidt EB, et al. BLTR1 and CD36 expressing microvesicles in atherosclerotic patients and healthy individuals. Front Cardiovasc Med 2018;5:156.
93. Pretorius L, Thomson GJA, Adams RCM, Nell TA, Laubscher WA, et al. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc Diabetol 2018;17:141.
94. Vítková V, Živný J, Janota J. Endothelial cell-derived microvesicles: potential mediators and biomarkers of pathologic processes. Biomark Med 2018;12:161-75.
95. Shi C, Ulke-Lemée A, Deng J, Batulan Z, O’Brien ER. Characterization of heat shock protein 27 in extracellular vesicles: a potential anti-inflammatory therapy. FASEB J 2019;33:1617-30.
96. Jansen F, Li Q, Pfeifer A, Werner N. Endothelial- and immune cell-derived extracellular vesicles in the regulation of cardiovascular health and disease. JACC Basic Transl Sci 2017;2:790-807.
97. Hutcheson JD, Aikawa E. Extracellular vesicles in cardiovascular homeostasis and disease. Curr Opin Cardiol 2018;33:290-7.
98. Jansen F, Nickenig G, Werner N. Extracellular vesicles in cardiovascular disease: potential applications in diagnosis, prognosis, and epidemiology. Circ Res 2017;120:1649-57.
99. Pardo F, Villalobos-Labra R, Sobrevia B, Toledo F, Sobrevia L. Extracellular vesicles in obesity and diabetes mellitus. Mol Aspects Med 2018;60:81-91.
100. Li F, Fang R, Rao L, Meng F, Zhao X. Research progress on exosomes in diagnosis and treatment of cardiovascular diseases. Zhejiang Da Xue Xue Bao Yi Xue Ban 2018;47:320-6. (in Chinese)
101. Dickhout A, Koenen RR. Extracellular vesicles as biomarkers in cardiovascular disease; chances and risks. Front Cardiovasc Med 2018;5:113.
102. Berezin AE, Kremzer A, Berezina T, Martovitskaya Y. The signature of circulating microparticles in heart failure patients with metabolic syndrome. J Circ Biomark 2016;5:1849454416663659.
103. Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA. The predictive role of circulating microparticles in patients with chronic heart failure. BBA Clin 2014;3:18-24.
104. Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis. Acta Clin Belg 2016;71:38-45.
105. Bei Y, Chen T, Banciu DD, Cretoiu D, Xiao J. Circulating exosomes in cardiovascular diseases. Adv Exp Med Biol 2017;998:255-69.
106. Zamani P, Fereydouni N, Butler AE, Navashenaq JG, Sahebkar A. The therapeutic and diagnostic role of exosomes in cardiovascular diseases. Trends Cardiovasc Med 2019;29:313-23.
